世界の心血管ペーシングおよび植え込み型除細動器（ICD）リード市場：医療機器パイプライン分析2016...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Overview 7
3 Products under Development 8
3.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products by Stage of Development 8
3.2 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products by Territory 9
3.3 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products by Regulatory Path 10
3.4 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products by Estimated Approval Date 11
3.5 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Ongoing Clinical Trials 12
4 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products under Development by Companies 13
4.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies – Pipeline Products by Stage of Development 13
4.2 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products by Stage of Development 14
5 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies and Product Overview 15
5.1 Boston Scientific Corporation Company Overview 15
5.1.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 Imricor Medical Systems, Inc. Company Overview 25
5.2.1 Imricor Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.3 LivaNova PLC Company Overview 26
5.3.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 26
5.4 Mayo Clinic US Company Overview 33
5.4.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 33
5.5 Medtronic plc Company Overview 35
5.5.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 35
5.6 MicroPort Scientific Corporation Company Overview 38
5.6.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 38
5.7 MRI Interventions, Inc Company Overview 40
5.7.1 MRI Interventions, Inc Pipeline Products & Ongoing Clinical Trials Overview 40
5.8 St. Jude Medical, Inc. Company Overview 42
5.8.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.9 Teleflex Incorporated Company Overview 49
5.9.1 Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview 49
6 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads- Recent Developments 50
6.1 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 50
6.2 May 04, 2016: Medtronic Welcomes Karen L. Parkhill as Its New Chief Financial Officer 52
6.3 Apr 28, 2016: Boston Scientific Announces Scheduled Presentation on Acuity X4 Quad LV Lead At Heart Rhythm Society 2016 53
6.4 Apr 27, 2016: Abbott Labs to Acquire St. Jude Medical for up to USD25 Billion 54
6.5 Apr 25, 2016: Boston Scientific Receives U.S. FDA Approval For ImageReady MR-Conditional Pacing System 54
6.6 Apr 20, 2016: BIOTRONIK ICD Lead Data from Long-Term Registries Published by Journal of Cardiovascular Electrophysiology 55
6.7 Apr 20, 2016: St. Jude Medical Reports First Quarter 2016 Results 56
6.8 Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury’s Recent Temporary and Proposed Regulations 57
6.9 Mar 29, 2016: St. Jude Medical Announces CE Mark Approval and Launch of Expanded Selection of Quadripolar Pacing Leads 57
6.10 Mar 17, 2016: Medtronic Proposes Proxy Access 59
6.11 Mar 01, 2016: Medtronic Reports Third Quarter Financial Results 59
6.12 Feb 23, 2016: Boston Scientific Receives U.S. FDA Approval For Quadripolar Leads And Initiates Global Trial To Expand MRI Labeling To The U.S. And Asia 61
6.13 Feb 19, 2016: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016 61
6.14 Feb 17, 2016: St. Jude Medical Receives FDA Approval for Industry’s First MultiPoint Pacing Technology 62
6.15 Jan 27, 2016: St. Jude Medical Reports Fourth Quarter and Full-Year 2015 Results 63
6.16 Jan 22, 2016: FDA Classifies St. Jude Medical Field Action for 447 of the Company’s Optisure High Voltage Leads as a Class 1 Advisory in the U.S. 65
6.17 Jan 13, 2016: St. Jude Medical Announces Preliminary Fourth Quarter 2015 Financial Results 66
6.18 Jan 11, 2016: Medtronic Updates Capital Allocation Plans and Fiscal 2016 EPS Guidance 67
6.19 Dec 14, 2015: The Medtronic Bakken Invitation Award Honors 12 Patients from Around the World for Giving Back 68
6.20 Nov 30, 2015: Boston Scientific Retrieves Certain Lots Of 9Fr ACUITY Pro Coronary Sinus Outer Guide Catheters 68
6.21 Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury’s Notice 2015-79 69
6.22 Oct 21, 2015: St. Jude Medical Reports Third Quarter 2015 Results 69
6.23 Sep 28, 2015: Medtronic InFuse Lawsuit May Reach Supreme Court, Parker Waichman LLP Comments 70
6.24 Sep 14, 2015: Incoming St. Jude Medical President and CEO Mike Rousseau Announces Executive Leadership Team 71
6.25 Sep 10, 2015: Sorin and Cyberonics Announce Appointment of LivaNova’s Chief Financial Officer 72
6.26 Sep 09, 2015: St. Jude Medical Announces Leadership Transition Plan 72
6.27 Sep 08, 2015: No Further Legal Action By Italian State’s Attorney To Enjoin The Combination Of Sorin And Cyberonics 73
6.28 Sep 03, 2015: Medtronic Reports First Quarter Financial Results 74
6.29 Aug 05, 2015: St. Jude Medical Appoints David Dvorak to Its Board of Directors 76
6.30 Jul 30, 2015: Sorin Group Announces Results for the Second Quarter of 2015 77
6.31 Jul 27, 2015: Sorin And Cyberonics Announce Intent To Vigorously Contest Claim By Italian State’s Attorney Seeking To Enjoin The Proposed Combination Of The Companies 79
6.32 Jul 22, 2015: St. Jude Medical Reports Second Quarter 2015 Results 80
6.33 Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean 81
6.34 Jun 25, 2015: Sorin And Cyberonics Unveil Name Of Combined Company: LivaNova 82
7 Appendix 84
7.1 Methodology 84
7.2 About GlobalData 86
7.3 Contact Us 87
7.4 Disclaimer 87